Radiant Research, Inc., a leading provider of clinical and consumer product testing, has expanded its consumer division.
Radiant Research, Inc., a leading provider of clinical and consumer product testing, has expanded its consumer division. This expansion includes additional geographic locations and increased product testing capabilities. The changes give Radiant’s consumer testing sites the ability to conduct studies in more diverse dermatological disease states, as well as in a varied demographical healthy normal population, with new bioinstrumentation resources.
“Radiant has become an industry leader in complex consumer trials since launching this specialized division in 2011,” said Tara Kelley, vice president of operations for Radiant Research. “Now, we’re giving our clients more options for their consumer testing needs by adding new locations and specialty populations. We’ve also made the process more efficient by integrating our consumer product and clinical trial database – giving us access to one million potential study participants.”
As part of its commitment to safe, effective and efficient consumer product testing, Radiant Research staffs clinical coordinators, recruitment specialists, technicians and medical research specialists at each site. Additionally, the sites are supported by a central team of experienced professionals who provide resources that are unmatched in the industry.
In addition to the wide range of claim support studies, Radiant Research has expanded its Dermal Safety testing to include the following: Cumulative Irritation, Phototoxicity, Contact Sensitization, Primary Irritation, Photoallergy and Transdermal Delivery Systems at multiple locations.
Radiant Research encourages those with consumer product testing needs to visithttp://www.radiantresearch.com and contact Charley Folk at 480-699-3406 or [email protected].
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.